Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications
Michael Crotty, MD, an expert in obesity medicine, discusses GLP-1RAs in the context of weight loss, including the novel dual agonist survodutide.
How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss
Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.
The Future of GLP-1RAs in Obesity Treatment: Expert Perspective
With the surge in demand and supply shortages, Michael Crotty, MD, discusses the future of GLP-1RA use in the treatment of obesity.
GLP-1RAs for Weight Management: Weighing Benefits vs Side Effects
Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.
